|
Status |
Public on Aug 01, 2018 |
Title |
Scr-4h |
Sample type |
RNA |
|
|
Source name |
P493-6 cells
|
Organism |
Homo sapiens |
Characteristics |
cell type: P493-6 treatment: scramble shRNA, 4h after Tet withdrawl
|
Treatment protocol |
P493-6 cells were infected with lentiviruses expressing control (scramble) or Dpy30 shRNAs #2 or #5, followed by puromycin (2 μg/ml) selection for 2–3 days starting from 2 days after infection. control and Dpy30 KD P493-6 cells were treated with tetracycline for 3 days (to turn off Myc). Tetracycline was thoroughly washed and cells were incubated in Tet-free medium for 4 hours. RNAs from cells before Tet treatment, after Tet treatment and right before washing Tet away, and 4h after washing Tet away, were subjected to Illumina microarray analyses.
|
Growth protocol |
P493-6 cells were cultured in RPMI 1640 medium with 10% fetal bovine serum (FBS).
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNAs were extracted using the RNeasy kit (Qiagen).
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion Illumina TotalPrep RNA Amplification kit for Illumina arrays
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Data processing |
Only Gene probes with Detection P value below 0.05 in at least one samples were kept for further processing including normalization. Signals were normalized against the median in each sample.
|
|
|
Submission date |
Jul 25, 2017 |
Last update date |
Aug 01, 2018 |
Contact name |
Hao Jiang |
E-mail(s) |
haojiang@uab.edu
|
Organization name |
University of Alabama at Birmingham
|
Department |
Biochemistry and Molecular Genetics
|
Street address |
1825 University Blvd
|
City |
Birmingham |
State/province |
AL |
ZIP/Postal code |
35294 |
Country |
USA |
|
|
Platform ID |
GPL10558 |
Series (2) |
GSE101852 |
Dpy30 regulates Myc binding to targets and Myc-driven tumorigenesis (Illumina HumanHT-12 V4.0 expression) |
GSE101854 |
Dpy30 regulates Myc binding to targets and Myc-driven tumorigenesis |
|